BRUNSWICK CORP (BC) Stock Fundamental Analysis

NYSE:BC • US1170431092

86.17 USD
-0.55 (-0.63%)
At close: Feb 12, 2026
86.17 USD
0 (0%)
After Hours: 2/12/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BC. BC was compared to 31 industry peers in the Leisure Products industry. There are concerns on the financial health of BC while its profitability can be described as average. BC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BC had positive earnings in the past year.
  • BC had a positive operating cash flow in the past year.
  • BC had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of BC (-2.58%) is comparable to the rest of the industry.
  • BC's Return On Equity of -8.45% is in line compared to the rest of the industry. BC outperforms 45.16% of its industry peers.
  • BC has a better Return On Invested Capital (5.91%) than 67.74% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BC is in line with the industry average of 7.65%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • With a decent Operating Margin value of 5.83%, BC is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BC has declined.
  • The Gross Margin of BC (24.84%) is worse than 61.29% of its industry peers.
  • In the last couple of years the Gross Margin of BC has declined.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BC is destroying value.
  • The number of shares outstanding for BC has been reduced compared to 1 year ago.
  • BC has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BC has an improved debt to assets ratio.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BC has a debt to FCF ratio of 5.30. This is a neutral value as BC would need 5.30 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.30, BC is doing good in the industry, outperforming 61.29% of the companies in the same industry.
  • BC has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • BC has a Debt to Equity ratio of 1.11. This is in the lower half of the industry: BC underperforms 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z N/A
ROIC/WACC0.65
WACC9.08%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • BC's Current ratio of 1.44 is on the low side compared to the rest of the industry. BC is outperformed by 70.97% of its industry peers.
  • A Quick Ratio of 0.61 indicates that BC may have some problems paying its short term obligations.
  • The Quick ratio of BC (0.61) is worse than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • BC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.29%.
  • Measured over the past years, BC shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.40% on average per year.
  • Looking at the last year, BC shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.79% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BC will show a small growth in Revenue. The Revenue will grow by 5.06% on average per year.
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y28.79%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.35 indicates a quite expensive valuation of BC.
  • Based on the Price/Earnings ratio, BC is valued a bit cheaper than 64.52% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BC to the average of the S&P500 Index (27.67), we can say BC is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 19.80, BC is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, BC is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
  • BC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.35
Fwd PE 19.8
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BC is cheaper than 64.52% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BC is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.14
EV/EBITDA 12.37
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BC's earnings are expected to grow with 30.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y27.83%
EPS Next 3Y30.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • BC has a Yearly Dividend Yield of 1.98%.
  • Compared to an average industry Dividend Yield of 1.25, BC pays a bit more dividend than its industry peers.
  • BC's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

  • On average, the dividend of BC grows each year by 11.57%, which is quite nice.
  • BC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.57%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • The earnings of BC are negative and hence is the payout ratio. BC will probably not be able to sustain this dividend level.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

BRUNSWICK CORP

NYSE:BC (2/12/2026, 8:04:00 PM)

After market: 86.17 0 (0%)

86.17

-0.55 (-0.63%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners110.83%
Inst Owner Change-1.17%
Ins Owners0.94%
Ins Owner Change-0.93%
Market Cap5.60B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts75.71
Price Target89.89 (4.32%)
Short Float %4.57%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend1.72
Dividend Growth(5Y)11.57%
DP-82.01%
Div Incr Years12
Div Non Decr Years16
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)15.85%
PT rev (3m)19.89%
EPS NQ rev (1m)-29.35%
EPS NQ rev (3m)-30.38%
EPS NY rev (1m)1.98%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)2.6%
Revenue NY rev (3m)4.85%
Valuation
Industry RankSector Rank
PE 26.35
Fwd PE 19.8
P/S 1.05
P/FCF 14.14
P/OCF 9.97
P/B 3.45
P/tB 62.55
EV/EBITDA 12.37
EPS(TTM)3.27
EY3.79%
EPS(NY)4.35
Fwd EY5.05%
FCF(TTM)6.09
FCFY7.07%
OCF(TTM)8.64
OCFY10.03%
SpS82.45
BVpS24.99
TBVpS1.38
PEG (NY)0.8
PEG (5Y)N/A
Graham Number42.88
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5Y-2.77%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 250
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z N/A
F-Score5
WACC9.08%
ROIC/WACC0.65
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.12%
EPS Next 2Y27.83%
EPS Next 3Y30.21%
EPS Next 5Y28.79%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year8.17%
Revenue Next 2Y6.68%
Revenue Next 3Y6.69%
Revenue Next 5Y5.06%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year98.59%
EBIT Next 3Y35.47%
EBIT Next 5Y26.24%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the valuation of BRUNSWICK CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUNSWICK CORP (BC) is 26.35 and the Price/Book (PB) ratio is 3.45.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.